Diabetes Therapy
Naringin improves hypoglycemia and reduces antioxidant activity
Published in Obesity and Diabetes Week, February 14th, 2005
According to a study from Egypt, "The effect of various doses (0, 10, 20, 40, or 80 mg/kg body weight) of naringin (a citrus flavonone) was studied on streptozotocin (STZ)-induced hyperglycemic rats to evaluate the possible hypoglycemic and antioxidant activity of naringin in diabetes."
"In comparison to the normoglycemic group the treatment of rats with a single dose of STZ (65 mg/kg body weight) only revealed a significant increase (p<0.05) in plasma hydrogen peroxide (H2 O2 ) by 230%, increased the thiobarbituric acid reactive...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Pathogenesis
Linkage analysis conducted of diabetes among hypertensive families - Diabetes Therapy
Researchers' work adds to diabetes therapy body of knowledge - Diabetes Therapy
Structure of GIP fragment determined - Diabetic Cardiomyopathy
Hyperglycemia produces cardiac abnormalities in rats fed PUFA-rich diet - Obesity and Diabetes
Effective treatments for insulin resistance reviewed - Obesity and Diabetes
Palmitate induces IL-6 expression in coronary artery endothelial cells - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
